Imagion Biosystems is a biotech company aiming to make a difference to the lives of cancer patients, with groundbreaking imaging techniques being trialled in Australian hospitals.
CEO Bob Proulx joins Sean Aylmer from San Diego to talk about Imagion's work, and why they chose to list on the ASX.

Afternoon Report | Attempted bombing declared terrorism
04:37

CGT scale back for property investors; tech stocks hammered; $US500b crypto sell-off
17:22

Q+A: After all the hype, green investing is 'growing up, not winding down'
11:31